同时的尼沃卢马布诱导心肌炎和严重肌痛性肌痛症:一个病例报告
Rajat Gupta1, Noorine Plumber1, Jae Lee2
1Department of Internal Medicine-GME, Northeast Georgia Medical Center, Gainesville, Georgia, USA.
Case reports in oncological medicine
|March 12, 2026
概括
这份病例报告详细介绍了一名老年患者,在治疗状黑色素瘤后,他患上了严重的心肌炎和严重骨髓灰质炎. 早期诊断和治疗对于管理这些罕见的免疫相关不良事件至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- 像尼沃卢马布这样的免疫检查点抑制剂 (ICI) 可以改善晚期黑色素瘤的存活率,但会带来与免疫相关的不良事件 (irAEs) 的风险.
- 阿克拉性黑色素瘤是一种罕见的亚型,通常呈现晚期,需要积极的治疗,包括免疫疗法.
- 严重的irrAEs,如心脏毒性和神经肌肉并发症,可以在ICI使用时发生.
研究的目的:
- 报告尼沃卢马布诱导的心肌炎和骨髓灰质炎的罕见病例,该病例发生在患有状黑色素瘤的老年患者身上.
- 突出早期识别和管理这些严重的IRE的重要性.
主要方法:
- 一名72岁的男性患有IIB期状黑色素瘤,接受了辅助药尼沃卢马布.
- 记录了临床表现,诊断工作 (包括心脏MRI,EMG) 和治疗干预措施.
- 监测了患者的结果和随后的心脏事件.
主要成果:
- 患者在第一个尼沃卢马布剂量后3周内发生了与免疫相关的3级心肌炎和3级尼沃卢马布诱导的骨髓衰竭.
- 用皮质类固醇和IVIG治疗导致症状消失和心脏功能改善.
- 患者后来经历了心房动,需要住院治疗和心脏转移.
结论:
- 尼沃卢马布诱导的心肌炎和严重心肌需要高度的临床怀疑,以便及时诊断和管理.
- 早期停止ICI和积极的免疫抑制对于管理这些严重的IRE至关重要.
- 多学科的护理和个性化的风险/益处评估至关重要,尤其是在考虑重新挑战ICI时.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...